RxDoctor Payments Data

Katherine Jones

Family · Mantachie, MSNPI 1851029409

Payments from drug & device makers

$1,084in general payments, 2019–2025

Across 68 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$298
  • AstraZeneca$153
  • Lilly USA, LLC$111
  • Corcept Therapeutics$77
  • Xeris Pharmaceuticals, Inc.$77
  • Pfizer$76
  • plus $292 from 7 others

What the payments were for

  • Food & beverage$1,084100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,084 in reported general payments places this provider in the 70th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$44,362
Medicare patients
170
Services billed
2,242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide32$45,871
OzempicSemaglutide24$35,551
FarxigaDapagliflozin Propanediol17$14,582
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,832
Rosuvastatin Calcium49$2,072
Cefdinir29$477
Gabapentin37$433
Omeprazole18$409
Amitriptyline Hcl11$338
Ropinirole Hcl25$308
Tramadol Hcl17$283
Losartan Potassium27$276
Levothyroxine Sodium20$269
Sertraline Hcl13$247
Amlodipine Besylate21$227

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$111$45,87132 claims
Novo NordiskOzempic$298$35,55124 claims
AstraZenecaFarxiga$153$14,58217 claims
GSKTrelegy Ellipta$60$6,83211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,007 family providers in Mississippi.

Other family in Mantachie

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →